| pubmed-article:14636901 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14636901 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:14636901 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:14636901 | lifeskim:mentions | umls-concept:C0949700 | lld:lifeskim |
| pubmed-article:14636901 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:14636901 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:14636901 | pubmed:dateCreated | 2003-11-25 | lld:pubmed |
| pubmed-article:14636901 | pubmed:abstractText | Patients with normal dobutamine stress echocardiography (DSE) were shown to have a favorable outcome at an intermediate-term follow-up. However, there are scarce data regarding long-term survival after normal DSE. This study sought to assess the long-term outcome after normal DSE. We studied 401 patients (age 62 +/- 10 years, 264 men) who had a normal echocardiogram at rest and with high-dose dobutamine stress. End points during a mean follow-up of 5 +/- 1.7 years (minimum 3.5) were all-cause mortality and hard cardiac events (cardiac death and nonfatal myocardial infarction). During follow-up, 45 patients (11%) died due to various causes (cardiac death in 10 patients). Thirteen patients had nonfatal myocardial infarction (a total of 23 hard cardiac events). The annual mortality rate was 2% in the first 3 years and 2.4% between the fourth and sixth years. The annual hard cardiac event rate was 0.8% in the first 3 years and 1.7% between the fourth and sixth years. Predictors of mortality in a multivariate analysis model were advanced age (hazard ratio 1.2, 95% confidence interval CI 1.1 to 1.4) and higher heart rate at rest (hazard ratio 0.92, 95% confidence interval 0.85 to 0.99). Patients with normal DSE had excellent outcomes during the 3 years after the study. The cardiac event rate was higher between the fourth and sixth year; therefore, it may be useful to repeat the study after 3 years to reassess risk status. | lld:pubmed |
| pubmed-article:14636901 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14636901 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14636901 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:14636901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14636901 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14636901 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14636901 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:14636901 | pubmed:issn | 0002-9149 | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:ElhendyAbdouA | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:VourvouriElen... | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:PoldermansDon... | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:SozziFabiola... | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:RoelandtJos... | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:BaxJeroen JJJ | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:SchinkelArend... | lld:pubmed |
| pubmed-article:14636901 | pubmed:author | pubmed-author:RizzelloVitto... | lld:pubmed |
| pubmed-article:14636901 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14636901 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:14636901 | pubmed:volume | 92 | lld:pubmed |
| pubmed-article:14636901 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14636901 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14636901 | pubmed:pagination | 1267-70 | lld:pubmed |
| pubmed-article:14636901 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:meshHeading | pubmed-meshheading:14636901... | lld:pubmed |
| pubmed-article:14636901 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14636901 | pubmed:articleTitle | Long-term prognosis after normal dobutamine stress echocardiography. | lld:pubmed |
| pubmed-article:14636901 | pubmed:affiliation | Department of Cardiology, IRCCS, Ospedale Maggiore, Milan, Italy. | lld:pubmed |
| pubmed-article:14636901 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14636901 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14636901 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14636901 | lld:pubmed |
